133 related articles for article (PubMed ID: 1392703)
1. Detecting susceptibility to malignant hyperthermia.
Ellis FR
BMJ; 1992 Mar; 304(6830):791-2. PubMed ID: 1392703
[No Abstract] [Full Text] [Related]
2. Current diagnostic methods of malignant hyperthermia: an evaluation.
Ording H
Acta Anaesthesiol Belg; 1990; 41(2):103-6. PubMed ID: 2371801
[No Abstract] [Full Text] [Related]
3. Malignant hyperthermia and central core disease: analysis of two families with heterogeneous clinical expression.
Romero NB; Nivoche Y; Lunardi J; Bruneau B; Cheval MA; Hillaire D; Fardeau M
Neuromuscul Disord; 1993; 3(5-6):547-51. PubMed ID: 8186709
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of susceptibility to malignant hyperthermia with flanking DNA markers.
Healy SJ; Heffron JJ; Lehane M; Bradley DG; Johnson K; McCarthy TV
BMJ; 1991 Nov; 303(6812):1225-8. PubMed ID: 1684123
[TBL] [Abstract][Full Text] [Related]
5. Diagnosing malignant hyperthermia susceptibility.
Hopkins PM; Halsall PJ; Ellis FR
Anaesthesia; 1994 May; 49(5):373-5. PubMed ID: 8209973
[No Abstract] [Full Text] [Related]
6. How carefully can we phenotype patients suspected of malignant hyperthermia susceptibility?
Larach MG; MacLennan DH
Anesthesiology; 1999 Mar; 90(3):645-8. PubMed ID: 10078661
[No Abstract] [Full Text] [Related]
7. European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility.
Hopkins PM; Rüffert H; Snoeck MM; Girard T; Glahn KP; Ellis FR; Müller CR; Urwyler A;
Br J Anaesth; 2015 Oct; 115(4):531-9. PubMed ID: 26188342
[TBL] [Abstract][Full Text] [Related]
8. Evidence of malignant hyperthermia in patients administered triggering agents before malignant hyperthermia susceptibility identified: missed opportunities prior to diagnosis.
Chan TY; Bulger TF; Stowell KM; Gillies RL; Langton EE; Street NE; Pollock NA
Anaesth Intensive Care; 2017 Nov; 45(6):707-713. PubMed ID: 29137581
[TBL] [Abstract][Full Text] [Related]
9. [Malignant hyperthermia: case-finding of subjects at risk].
Viering WA; Sengers RC; Stadhouders AM; Gielen MJ; Festen C
Ned Tijdschr Geneeskd; 1986 May; 130(22):1002-4. PubMed ID: 3724881
[No Abstract] [Full Text] [Related]
10. Recent developments in the molecular genetics of malignant hyperthermia: implications for future diagnosis at the DNA level.
McCarthy TV; Healy JM; Lehane M; Heffron JJ
Acta Anaesthesiol Belg; 1990; 41(2):107-12. PubMed ID: 1973552
[TBL] [Abstract][Full Text] [Related]
11. Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q12-q13.2.
Healy JM; Lehane M; Heffron JJ; Farrell M; Johnson K; McCarthy TV
Biochem Soc Trans; 1990 Apr; 18(2):326. PubMed ID: 2379741
[No Abstract] [Full Text] [Related]
12. Malignant hyperthermia.
Glisson SN
Compr Ther; 1988 Oct; 14(10):33-41. PubMed ID: 3053015
[No Abstract] [Full Text] [Related]
13. Ambulatory laboratory investigations for malignant hyperthermia susceptible patients.
Ellis FR
Acta Anaesthesiol Belg; 1988; 39(3 Suppl 2):253-4. PubMed ID: 3176861
[No Abstract] [Full Text] [Related]
14. Genomic Screening for Malignant Hyperthermia Susceptibility.
Biesecker LG; Dirksen RT; Girard T; Hopkins PM; Riazi S; Rosenberg H; Stowell K; Weber J
Anesthesiology; 2020 Dec; 133(6):1277-1282. PubMed ID: 32898259
[TBL] [Abstract][Full Text] [Related]
15. DNA analysis and malignant hyperthermia susceptibility.
Stowell KM; Pollock N
Anaesth Intensive Care; 2008 May; 36(3):305-7. PubMed ID: 18564791
[No Abstract] [Full Text] [Related]
16. Malignant hyperthermia.
Willner J
Pediatr Ann; 1984 Feb; 13(2):128, 130, 132-4. PubMed ID: 6369232
[No Abstract] [Full Text] [Related]
17. [Diagnosis of susceptibility to malignant hyperthermia in children].
Krivosic-Horber R; Adnet P; Krivosic I; Reyford H
Arch Fr Pediatr; 1990; 47(6):421-4. PubMed ID: 2403268
[TBL] [Abstract][Full Text] [Related]
18. [What significance to genotype changes have in diagnosis of malignant hyperthermia?].
Steinfath M; Scholz J; Singh S; Wappler F
Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Aug; 31(6):334-43. PubMed ID: 8962927
[TBL] [Abstract][Full Text] [Related]
19. [The investigation of malignant hyperthermia susceptibility].
Glahn KP
Ugeskr Laeger; 2016 May; 178(18):. PubMed ID: 27137116
[TBL] [Abstract][Full Text] [Related]
20. The genetics of malignant hyperthermia: evidence for heterogeneity.
McPherson E; Taylor CA
Am J Med Genet; 1982 Mar; 11(3):273-85. PubMed ID: 7081293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
